Altamira Therapeutics shares are trading lower after the company announced pricing of a $5 million public offering.
Portfolio Pulse from Benzinga Newsdesk
Altamira Therapeutics has announced the pricing of a $5 million public offering, leading to a decrease in its share price.
July 06, 2023 | 12:27 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Altamira Therapeutics' stock price is trading lower after the company announced a $5 million public offering.
Public offerings often lead to a decrease in share price due to dilution of shares. In this case, Altamira Therapeutics' announcement of a $5 million public offering has led to a decrease in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100